Global regulatory authorities have been raising the expectation of incorporating quality by design (QbD) into pharmaceutical development.

Problem: According to the Allotrope Foundation, “Underpinning every experiment, every scientific decision, and every regulatory submission is data generated by a scientist using an instrument in the laboratory.” These mountains of analytical data are analyzed and interpreted in global R&D laboratories to help evaluate, identify, and characterize compounds and formulations.